ReviewSmall science2025
Label-Free Electrochemical Impedance Spectroscopy for Biosensing: Evolving Interfaces and Mechanistic Insights.
Review in Small science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Progress in (Photo)electrochemical Biosensors for the Detection of Amyloid-Beta Oligomer.Biosensors · 2026Review
- Electrochemical liquid biopsy across cancer care pathway.The journal of liquid biopsy · 2026Review
- Cell-Based Immuno-Biosensors Using Microfluidics.Sensors (Basel, Switzerland) · 2026Review
- Label-Free Electrochemical Impedance Spectroscopy for Biosensing: Evolving Interfaces and Mechanistic Insights.Small science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The evolution of label-free electrochemical biosensors has revolutionized the field of analytical detection by enabling rapid, direct, and sensitive detection of a wide range of analytes. Electrochemical impedance spectroscopy (EIS) provides mechanistic insight into the interfacial changes occurring at the electrode/electrolyte interface, thereby enabling real-time monitoring. Direct detection of molecular binding events at the electrode interface is made possible by sensing measurable shifts in interfacial impedance characteristics. Despite their versatility, the commercial translation of EIS-enabled biosensors has been hindered by challenges in achieving robust sensitivity, specificity, and reproducibility. Recent progress in the field, including integration of nanoengineered electrode materials and novel biorecognition elements, has addressed some of these limitations, resulting in marked improvements in EIS-based biosensor performance. This review discusses the mechanistic principles underlying label-free EIS biosensing and highlights recent developments in electrode surface modification and sensor architecture. It also explores the integration of novel biorecognition elements and describes how their impact on sensor performance may be assessed. Current limitations and future directions for the application of EIS-enabled sensors in clinical diagnostics, environmental analysis, and food safety monitoring are also considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.